News

We’ve rounded up a list of important US Food and Drug Administration (FDA) recalls from this week.

Since August of 2017, there have been 1,170 cases of hepatitis A in Kentucky, resulting in 658 hospitalizations and 8 deaths.

Genital shedding in herpes patients is even more common than genital lesions. Can a new way of testing for the disease streamline the treatment process?

OSA is largely untreated in HIV patients, and this lack of treatment likely contributes to further comorbidity complications associated with the virus.

As more and more health care organizations embrace environmental sustainability, experts say epidemiologists need to have a seat at the table to stave off infection control and prevention concerns.

The FDA has indicated that whey powder is a common ingredient in 3 products recalled this week for potential Salmonella contamination.

We know we have a problem with isolation precaution compliance, but just how bad is it?

Eradication of HCV in patients with HIV results in reduction of CD4+ and CD8+ T cell immune activation.

At week 96, 73.1% of patients infected with HIV-1 and treated with once-daily doravirine + other ART medications, achieved viral suppression.

Millions with viral hepatitis go undiagnosed and untreated.

Dolutegravir and lamivudine combination regimen met primary endpoint in 2 phase 3 studies of treatment-naïve patients with HIV.

After 42 days without any new confirmed cases, the ninth Ebola outbreak in the Democratic Republic of the Congo is officially over.

Mosaic-based vaccine regimen maintained humoral and cellular HIV immune responses according to long-term data from APPROACH.

New guidelines on the prevention and treatment of HIV in adults from the IAS-USA Panel highlight advances made since the 2016 guidelines, as well as the need for new strategies.

PARTNER 2 study reports zero HIV transmissions over 8 years in gay couples who did not use condoms and had achieved an undetectable viral load on HIV treatment.

More information continues to come to light on the impact of protease inhibitors on patients with HIV and cardiovascular disease.

Alternative agents are often broader spectrum than ß-lactams, subjecting patients to collateral damage and subsequent selection for resistant organisms and Clostridium difficile.

A new study reports that PrEP users were more likely to receive more primary health care services compared with non-PrEP users.

Tafenoquine is the first single-dose medicine for the prevention of P vivax malaria relapse.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

New research reports that sentiments included in nursing notes can serve as an indicator of whether ICU patients will survive.

Treponemal immunoassays are now recommended as first-line tests for syphilis, with further testing required to confirm the diagnosis.

The World Health Organization has listed Uganda on its Zika travel advisory list, but now the country’s health minister is requesting removal from the list, citing no cases or outbreaks.

The CDC has announced an investigation of a multidrug-resistant outbreak of Salmonella Reading infections that have been linked with raw turkey.

A new review finds antibiotics aren’t effective for osteomyelitis in sacral pressure ulcers where the bone is exposed.

Treatment with azithromycin plus ivermectin versus ivermectin alone provides equal protection against scabies and impetigo in at-risk communities.

Study suggests that clinicians should perform confirmatory allergy testing on patients with reported penicillin allergies as an important feature of antimicrobial stewardship.